Arena

3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Arena
Vivus
Orexigen
Biocryst
BioSante
FDA panel to discuss Arena obesity drug in 2nd quarter
Reuters
Thu, 02/2/12 - 11:06 am
Arena
FDA
obesity
lorcaserin
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Minyanville
Fri, 01/13/12 - 10:26 am
Vivus
Arena
Orexigen
obesity
lorcaserin
Qnexa
Contrave
Arena says FDA accepts new filing for obesity drug lorcaserin, will make decision by June 27
Yahoo/AP
Tue, 01/10/12 - 06:04 pm
Arena
FDA
obesity
lorcaserin
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Arena Pharma says it sent the FDA more data on weight-loss drug candidate lorcaserin
Yahoo/AP
Tue, 01/3/12 - 06:55 pm
Arena
obesity
FDA
lorcaserin
Market Crash = Biotech Carnage
Motley Fool
Thu, 11/10/11 - 01:05 pm
biotech
Zalicus
Complete Genomics
Pacific Biosciences
Illumina
Arena
Vivus
Biotechs And Their Trials By Fire
Seeking Alpha
Mon, 11/7/11 - 11:57 am
MannKind
Keryx
Dendreon
Arena
Biocryst
Aeterna Zentaris
Advanced Cell Technologies
Is Arena's Lorcaserin On Track For Approval In 2012?
Seeking Alpha
Mon, 09/12/11 - 09:57 am
Arena
obesity
lorcaserin
Arena's experimental obesity drug lorcaserin beats placebo again
Yahoo/Reuters
Wed, 08/31/11 - 09:43 am
Arena
obesity
lorcaserin

Pages